Viking Therapeutics (VKTX) Tops Q1 EPS by 2c

Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($0.26), $0.02 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• INVO Fertility (IVF) Tops Q2 EPS by 105c
• Aon names interim CFO as Edmund Reese exits the firm